Given that similar trends were observed for MCP-1 and CD11b mRNA levels (Fig. 2D,E) and MCP-1 protein levels (Fig. 2H,I), these results indicate that the loss of MMP-12 function inhibits renal inflammation in glomerular disease progression resulting from HFD. This evidence concerns the gene CCL2 and glomerular disorder.